Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
23847studies shown
Showing 19,477-19,488 of 23,847
Drug study icon
CompletedNCT00579280

Quetiapine SR and Divalproex Sodium ER in the Treatment of Anxiety in Bipolarity With Panic Disorder and/or GAD

This study exists to compare options and see whether a therapy or guided support program offers something meaningfully different. Researchers are trying to understand whether a therapy or guided support program can improve sleep, daily rhythms, and longer-term stability.

Multiple locations, including Palo Alto
Bipolarity, AnxietyDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
University of South Florida
Condition
Bipolarity, Anxiety
Drug study icon
CompletedNCT01195363

Quetiapine Sr as Adjunctive Treatment In Mixed States of Bipolarity

This study exists to understand how this type of care holds up over time after the earliest research stage. Researchers are trying to understand what this type of care could change in day-to-day care and decision-making.

In San Antonio
BipolarityDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
The University of Texas Health Science Center at San Antonio
Condition
Bipolarity
Drug study icon
CompletedNCT00237393

Quetiapine Treatment for PTSD (PTSD)

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Albuquerque
PTSDDrugOver 18 Years
Countries
United States
Sponsor
Ralph H. Johnson VA Medical Center
Condition
PTSD
Drug study icon
TerminatedNCT00746421

Quetiapine XR for Cognitive and Functional Disability in Clinically Stable people with Bipolarity

This study exists to understand how a therapy or guided support program holds up over time after the earliest research stage. Researchers are trying to understand whether a therapy or guided support program can improve attention, thinking, or day-to-day functioning.

Multiple locations, including Atlanta
BipolarityDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Emory University
Condition
Bipolarity
Drug study icon
TerminatedNCT01071135

Quetiapine XR in Schizophrenic Patients

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Hanover
SchizophreniaDrugFrom 18 Years to 60 Years
Countries
Germany
Sponsor
Hannover Medical School
Condition
Schizophrenia
Behavioral study icon
CompletedNCT04946825

Quit Smoking Study for People Who Use E-Cigarettes

This summary needs review. Please check the official study record and contact the research team for details.

In Burlington
AddictionBehavioralFrom 18 Years to 29 Years
Countries
United States
Sponsor
University of Vermont
Condition
Addiction
Behavioral study icon
CompletedNCT05447156

QuitGuide for American Indians: Aims 2 & 3

This summary needs review. Please check the official study record and contact the research team for details.

In Minneapolis
AddictionBehavioralOver 18 Years
Countries
United States
Sponsor
Masonic Cancer Center, University of Minnesota
Condition
Addiction
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.